Therapeutic approach with mepolizumab (anti-IL-5) in a series of patients with eosinophilic granulomatosis with polyangiitis

被引:0
|
作者
Bizymi, N. [1 ]
Matthaiou, A. M. [1 ]
Stathakis, G. [1 ]
Viziriannaki, S. [1 ]
Bibaki, E. [1 ]
Tzanakis, N. [1 ]
Antoniou, K. [1 ]
机构
[1] Univ Crete, Sch Med, Dept Resp Med, Iraklion, Greece
关键词
Orphan diseases; Immunology; Pharmacology;
D O I
10.1183/13993003.congress-2022.3774
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
3774
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Haruki Koike
    Ryoji Nishi
    Satoru Yagi
    Soma Furukawa
    Yuki Fukami
    Masahiro Iijima
    Masahisa Katsuno
    Advances in Therapy, 2023, 40 : 25 - 40
  • [2] A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Koike, Haruki
    Nishi, Ryoji
    Yagi, Satoru
    Furukawa, Soma
    Fukami, Yuki
    Iijima, Masahiro
    Katsuno, Masahisa
    ADVANCES IN THERAPY, 2023, 40 (01) : 25 - 40
  • [3] Correction to: A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Haruki Koike
    Ryoji Nishi
    Satoru Yagi
    Soma Furukawa
    Yuki Fukami
    Masahiro Iijima
    Masahisa Katsuno
    Advances in Therapy, 2023, 40 : 718 - 718
  • [4] Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis
    Stein, Miguel L.
    Collins, Margaret H.
    Villanueva, Joyce M.
    Kushner, Jonathan P.
    Putnam, Philip E.
    Buckmeier, Bridget K.
    Filipovich, Alexandra H.
    Assa'ad, Amal H.
    Rothenberg, Marc E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (06) : 1312 - 1319
  • [5] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis
    Moiseev, Sergey
    Zagvozdkina, Eugenia
    Kazarina, Viktoria
    Bulanov, Nikolai
    Novikov, Pavel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 621 - 621
  • [6] Remission of refractory eosinophilic gastrointestinal disease in an eosinophilic granulomatosis with polyangiitis patient by anti-IL-5 therapy
    Wang, Chrong-Reen
    Tsai, Hung-Wen
    Wu, I-Chin
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 (12) : 1345 - 1346
  • [7] The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis
    Nagase, Hiroyuki
    Ueki, Shigeharu
    Fujieda, Shigeharu
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (02) : 178 - 186
  • [8] Mepolizumab (anti-IL-5) reduces exacerbations in patients with refractory eosinophilic asthma
    Pavord, Ian
    Korn, Stephanie
    Howarth, Peter
    Bleecker, Eugene
    Buhl, Roland
    Keene, Oliver
    Ortega, Hector
    Pascal, Pascal Chanez
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Mepolizumab for eosinophilic granulomatosis with polyangiitis
    Loïc Guillevin
    Nature Reviews Rheumatology, 2017, 13 : 518 - 519
  • [10] Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis Reply
    Wechsler, Michael E.
    Pouliquen, Isabelle
    Steinfeld, Jonathan
    Bradford, Eric S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (02) : 622 - 622